Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Finke

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Psychiatry and Clinical Neurosciences|February 4, 2025
Two-year impact of COVID-19: Longitudinal MRI brain changes and neuropsychiatric trajectoriesRavi Dadsena, Julia Walders, Ana S Costa, et al.
Annals of Clinical and Translational Neurology|May 22, 2025
Brain Characteristics in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder by 7.0 Tesla MRILei Su, Joseph Kuchling, Chenyang Gao, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 12, 2020
E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disordersArlette L Bruijstens, Eva-Maria Wendel, Christian Lechner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 22, 2023
Retrospective Pediatric Cohort Study Validates NEOS Score and Demonstrates Applicability in Children With Anti-NMDAR EncephalitisMarc Nikolaus, Philipp Rausch, Kevin Rostásy, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 2, 2021
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE RegistryFranziska S Thaler, Luise Zimmermann, Stefan Kammermeier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 1, 2023
Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 AntibodiesKatharina Eisenhut, Jennifer Faber, Daniel Engels, et al.
Brain, Behavior, and Immunity|August 14, 2024
Human cerebrospinal fluid monoclonal CASPR2 autoantibodies induce changes in electrophysiology, functional MRI, and behavior in rodent modelsScott van Hoof, Jakob Kreye, César Cordero-Gómez, et al.
Frontiers in Immunology|December 30, 2024
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitisSarah Jesse, Marie Riemann, Hauke Schneider, et al.
Eclinicalmedicine|September 22, 2022
Fatigue and cognitive impairment after COVID-19: A prospective multicentre studyTim J Hartung, Christian Neumann, Thomas Bahmer, et al.
Trials|August 20, 2025
Randomized adaptive assessment of post COVID syndrome treatments (RAPID): a study protocol for a multicenter, randomized, controlled adaptive platform trial of treatment options for Post Covid Syndrome (PCS) on patients physical function including the first intervention specific appendix RAPID_REVIVE (reducing inflammatory activity in patients with PCS)Lisa Weipert, Ralph G Telgmann, Gabriele Anton, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Psychiatry and Clinical Neurosciences|February 4, 2025
Two-year impact of COVID-19: Longitudinal MRI brain changes and neuropsychiatric trajectoriesRavi Dadsena, Julia Walders, Ana S Costa, et al.
Annals of Clinical and Translational Neurology|May 22, 2025
Brain Characteristics in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder by 7.0 Tesla MRILei Su, Joseph Kuchling, Chenyang Gao, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 12, 2020
E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disordersArlette L Bruijstens, Eva-Maria Wendel, Christian Lechner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 22, 2023
Retrospective Pediatric Cohort Study Validates NEOS Score and Demonstrates Applicability in Children With Anti-NMDAR EncephalitisMarc Nikolaus, Philipp Rausch, Kevin Rostásy, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 2, 2021
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE RegistryFranziska S Thaler, Luise Zimmermann, Stefan Kammermeier, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 1, 2023
Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 AntibodiesKatharina Eisenhut, Jennifer Faber, Daniel Engels, et al.
Brain, Behavior, and Immunity|August 14, 2024
Human cerebrospinal fluid monoclonal CASPR2 autoantibodies induce changes in electrophysiology, functional MRI, and behavior in rodent modelsScott van Hoof, Jakob Kreye, César Cordero-Gómez, et al.
Frontiers in Immunology|December 30, 2024
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitisSarah Jesse, Marie Riemann, Hauke Schneider, et al.
Eclinicalmedicine|September 22, 2022
Fatigue and cognitive impairment after COVID-19: A prospective multicentre studyTim J Hartung, Christian Neumann, Thomas Bahmer, et al.
Trials|August 20, 2025
Randomized adaptive assessment of post COVID syndrome treatments (RAPID): a study protocol for a multicenter, randomized, controlled adaptive platform trial of treatment options for Post Covid Syndrome (PCS) on patients physical function including the first intervention specific appendix RAPID_REVIVE (reducing inflammatory activity in patients with PCS)Lisa Weipert, Ralph G Telgmann, Gabriele Anton, et al.
Pageof 18